SCHEMBL28224943

SCHEMBL28224943

O=C(N[C@H](C(=O)O)c1ccc(F)cc1)OCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.64
CTSL P07711 1/20 0.56
CTSS P25774 1/20 0.56
OPRK1 P41145 1/20 0.52
CYP3A4 P08684 3/20 0.50
CTRB1 P17538 2/20 0.50
TSHR P16473 2/20 0.50
MGLL Q99685 1/20 0.50
CYP2D6 P10635 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
CNR2 P34972 1/20 0.49
ALDH1A1 P00352 1/20 0.48
CASP1 P29466 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28224944 1.00 ATM (0.64) ATMCTSLCTSSOPRK1CYP3A4
SCHEMBL434233 0.90 ATM (0.77) ATMCTSLCTSSOPRK1CYP3A4
SCHEMBL1362502 0.90 ATM (0.77) ATMCTSLCTSSOPRK1CYP3A4
SCHEMBL7719287 0.90 ATM (0.77) ATMCTSLCTSSOPRK1CYP3A4
SCHEMBL3255533 0.90 ATM (0.77) ATMCTSLCTSSOPRK1CYP3A4
SCHEMBL5742261 0.89 ATM (0.67) ATMCTSLCTSSCYP3A4CTRB1
SCHEMBL5742255 0.89 ATM (0.67) ATMCTSLCTSSCYP3A4CTRB1
SCHEMBL17765000 0.89 ATM (0.67) ATMCTSLCTSSCYP3A4CTRB1
SCHEMBL11205232 0.86 ATM (0.64) ATMCTSLCTSSCTRB1CNR2
SCHEMBL12033397 0.85 ATM (0.60) ATMCTSLCTSSCTRB1MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108148060-B Substituted heterocyclic compound and derivative thereof, pharmaceutical composition, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2020-06-19 CN disclosed
CN-108148060-A Substituted heterocyclic compound and its derivative, pharmaceutical composition, Preparation method and use 四川科伦博泰生物医药股份有限公司 2018-06-12 CN disclosed